CLINICAL_TRIALS
trial_result
· 2024-08-20
Clinical Trial Update: Pilot Randomized Trial With Flecainide in ARVC Patients [Phase 2]
Summary
A Phase 2 pilot randomized trial evaluated flecainide in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC); the study is completed and result…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Rochester | Conditions: Arrhythmogenic Right Ventricular Cardiomyopathy | Phase 2 | Status: COMPLETED | Results posted: 2024-08-20